West Pharmaceutical Servi... (WST)
West Pharmaceutical Services Statistics
Share Statistics
West Pharmaceutical Services has 72.29M shares outstanding. The number of shares has increased by -0.76% in one year.
| Shares Outstanding | 72.29M |
| Shares Change (YoY) | -0.76% |
| Shares Change (QoQ) | -0.18% |
| Owned by Institutions (%) | 95.73% |
| Shares Floating | 71.88M |
| Failed to Deliver (FTD) Shares | 32 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.43M, so 1.97% of the outstanding shares have been sold short.
| Short Interest | 1.43M |
| Short % of Shares Out | 1.97% |
| Short % of Float | 2.59% |
| Short Ratio (days to cover) | 1.61 |
Valuation Ratios
The PE ratio is 48.53 and the forward PE ratio is 28.45. West Pharmaceutical Services's PEG ratio is -3.13.
| PE Ratio | 48.53 |
| Forward PE | 28.45 |
| PS Ratio | 8.26 |
| Forward PS | 4 |
| PB Ratio | 8.91 |
| P/FCF Ratio | 86.51 |
| PEG Ratio | -3.13 |
Enterprise Valuation
West Pharmaceutical Services has an Enterprise Value (EV) of 23.73B.
| EV / Sales | 8.2 |
| EV / EBITDA | 31.9 |
| EV / EBIT | 36.32 |
| EV / FCF | 85.85 |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.79 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.09 |
| Interest Coverage | 189.97 |
Financial Efficiency
Return on Equity is 18.37% and Return on Invested Capital is 14.96%.
| Return on Equity | 18.37% |
| Return on Assets | 13.52% |
| Return on Invested Capital | 14.96% |
| Revenue Per Employee | $272.94K |
| Profits Per Employee | $46.48K |
| Employee Count | 10,600 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 5.03 |
Taxes
| Income Tax | 107.5M |
| Effective Tax Rate | 18.36% |
Stock Price Statistics
The stock price has increased by -46.54% in the last 52 weeks. The beta is 1.22, so West Pharmaceutical Services's price volatility has been higher than the market average.
| Beta | 1.22 |
| 52-Week Price Change | -46.54% |
| 50-Day Moving Average | 229.6 |
| 200-Day Moving Average | 293.32 |
| Relative Strength Index (RSI) | 36.7 |
| Average Volume (20 Days) | 1.05M |
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 2.89B and earned 492.7M in profits. Earnings per share was 6.75.
| Revenue | 2.89B |
| Gross Profit | 998.5M |
| Operating Income | 569.9M |
| Net Income | 492.7M |
| EBITDA | 743.9M |
| EBIT | 588.5M |
| Earnings Per Share (EPS) | 6.75 |
Balance Sheet
The company has 484.6M in cash and 302.3M in debt, giving a net cash position of 182.3M.
| Cash & Cash Equivalents | 484.6M |
| Total Debt | 302.3M |
| Net Cash | 182.3M |
| Retained Earnings | 3.96B |
| Total Assets | 3.64B |
| Working Capital | 987.7M |
Cash Flow
In the last 12 months, operating cash flow was 653.4M and capital expenditures -377M, giving a free cash flow of 276.4M.
| Operating Cash Flow | 653.4M |
| Capital Expenditures | -377M |
| Free Cash Flow | 276.4M |
| FCF Per Share | 3.79 |
Margins
Gross margin is 34.51%, with operating and profit margins of 19.7% and 17.03%.
| Gross Margin | 34.51% |
| Operating Margin | 19.7% |
| Pretax Margin | 20.24% |
| Profit Margin | 17.03% |
| EBITDA Margin | 25.71% |
| EBIT Margin | 19.7% |
| FCF Margin | 9.55% |
Dividends & Yields
WST pays an annual dividend of $0.83, which amounts to a dividend yield of 0.4%.
| Dividend Per Share | $0.83 |
| Dividend Yield | 0.4% |
| Dividend Growth (YoY) | 5% |
| Payout Ratio | 12.41% |
| Earnings Yield | 2.06% |
| FCF Yield | 1.16% |
Analyst Forecast
The average price target for WST is $355, which is 76% higher than the current price. The consensus rating is "Buy".
| Price Target | $355 |
| Price Target Difference | 76% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Sep 27, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 2013 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 12.68 |
| Piotroski F-Score | 6 |